₹708.15
+₹1.35 (+0.19%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹11,261 Cr
P/E
36.48
ROE
8.89%
ROCE
10.37%
About Jubilant Ingrevia Ltd
Jubilant Ingrevia The Group is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative,
Founded
2019
CEO
Shyam S Bhartia
Employees
3,425
HQ
Amroha, India
About Jubilant Ingrevia Ltd
Jubilant Ingrevia The Group is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative,
Founded:2019
CEO:Shyam S Bhartia
Employees:3,425
HQ:Amroha, India
Finished Products
1Sale of Products
₹7,828.37Cr2Other Operating Revenue
₹48.28Cr3Government Grant
₹23.56Cr4Scrap Sales
₹23.55Cr5Sale of Services
₹4.71CrRaw Materials
1Cost of Raw Materials Consumed
₹4,098.80Cr2Purchase of Stock-in-Trade
₹100.71CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹795
52W Low
₹537
Volume90.75K
Avg VolumeN/A
Beta1.23
Dividend Yield0.71%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
36.48x
Valuation
P/B Ratio
3.51x
Valuation
EPS
₹19.38
Valuation
Dividend Yield
0.71%
Valuation
ROE
8.89%
Profitability
ROCE
10.37%
Profitability
Revenue by Segment
Contribution & growth by business line
Speciality Chemicals
+14.7%43.5%
₹1,817.97 Cr
Chemical Intermediates
-13.8%38.6%
₹1,612.3 Cr
Nutrition & Health Solutions
+9.9%17.9%
₹747.35 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
54.1%
International
45.9%
India54.1%
Americas and Europe35.7%
Rest of the world7.3%
China2.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.25x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
2.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.